Meredith A. Achey

Meredith A. Achey

Auto-generated profile, based on publicly available information

Meredith A. Achey

Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2017 in Neurology
Verified
Journal Article
Closed access
PDF file
CBChristopher A. Beck
Christopher A. Beck
DBDenise B. Beran
Denise B. Beran
KBKevin M. Biglan
Kevin M. Biglan
CBCynthia M. Boyd
Cynthia M. Boyd
EDE. Ray Dorsey
E. Ray Dorsey
WZWilliam Zhu
William Zhu
Objective: To determine whether providing remote neurologic care into the homes of people with Parkinson disease (PD) is feasible, beneficial, and valuable. Methods: In a 1-year randomized controlled trial, we compared usual care to usual care supplemented by 4 virtual visits via video conferencing from a remote specialist into patients9 homes. Primary outcome measures were feasibility, as measured by the proportion who completed at least one virtual visit and the proportion of virtual visits completed on time; and efficacy, as measured by the change in the Parkinson9s Disease Questionnaire–39, a quality of life scale. Secondary outcomes included quality of care, caregiver burden, and time and travel savings. Results: A total of 927 individuals indicated interest, 210 were enrolled, and 195 were randomized. Participants had recently seen a specialist (73%) and were largely college-educated (73%) and white (96%). Ninety-five (98% of the intervention group) completed at least one virtual visit, and 91% of 388 virtual visits were completed. Quality of life did not improve in those receiving virtual house calls (0.3 points worse on a 100-point scale; 95% confidence interval [CI] −2.0 to 2.7 points; p = 0.78) nor did quality of care or caregiver burden. Each virtual house call saved patients a median of 88 minutes (95% CI 70–120; p < 0.0001) and 38 miles per visit (95% CI 36–56; p < 0.0001). Conclusions: Providing remote neurologic care directly into the homes of people with PD was feasible and was neither more nor less efficacious than usual in-person care. Virtual house calls generated great interest and provided substantial convenience. ClinicalTrials.gov identifier: NCT02038959. Classification of evidence: This study provides Class III evidence that for patients with PD, virtual house calls from a neurologist are feasible and do not significantly change quality of life compared to in-person visits. The study is rated Class III because it was not possible to mask patients to visit type.

17 May 2014 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
MAMeredith Achey
Meredith Achey
JAJason L. Aldred
Jason L. Aldred
NANoha Aljehani
Noha Aljehani
BBBastiaan R. Bloem
Bastiaan R. Bloem
KBKevin M. Biglan
Kevin M. Biglan
OFon behalf of the International Parkinson and Movement Disorder Society Telemedicine Task Force
on behalf of the International Parkinson and Movement Disorder Society Telemedicine Task Force

1 July 2016 in Telemedicine and e-Health
Verified
Journal Article
Closed access
EDE. Ray Dorsey
E. Ray Dorsey
MAMeredith A. Achey
Meredith A. Achey
CBChristopher A. Beck
Christopher A. Beck
DBDenise B. Beran
Denise B. Beran
KBKevin M. Biglan
Kevin M. Biglan
WZWilliam Zhu
William Zhu
Background: Delivering specialty care remotely directly into people's homes can enhance access for and improve the healthcare of individuals with chronic conditions. However, evidence supporting this approach is limited. Materials and Methods: Connect.Parkinson is a randomized comparative effectiveness study that compares usual care of individuals with Parkinson's disease in the community with usual care augmented by virtual house calls with a Parkinson's disease specialist from 1 of 18 centers nationally. Individuals in the intervention arm receive four virtual visits from a Parkinson's disease specialist over 1 year via secure, Web-based videoconferencing directly into their homes. All study activities, including recruitment, enrollment, and assessments, are conducted remotely. Here we report on interest, feasibility, and barriers to enrollment in this ongoing study. Results: During recruitment, 11,734 individuals visited the study's Web site, and 927 unique individuals submitted electronic interest forms. Two hundred ten individuals from 18 states enrolled in the study from March 2014 to June 2015, and 195 were randomized. Most participants were white (96%) and college educated (73%). Of the randomized participants, 73% had seen a Parkinson's disease specialist within the previous year. Conclusions: Among individuals with Parkinson's disease, national interest in receiving remote specialty care directly into the home is high. Remote enrollment in this care model is feasible but is likely affected by differential access to the Internet.

14 September 2015 in Journal of Parkinson’s Disease
Verified
Journal Article
Open access
PDF file
EDE. Ray Dorsey
E. Ray Dorsey
JWJoseph D. Wagner
Joseph D. Wagner
MBMichael T. Bull
Michael T. Bull
ARAshley Rizzieri
Ashley Rizzieri
JGJustin Grischkan
Justin Grischkan
KBKevin M. Biglan
Kevin M. Biglan
Background: Fox Trial Finder is an online registry for individuals with and without Parkinson disease (PD) interested in participating in PD research. However, distance or disability could prevent such individuals from participating in traditional,

1 January 2020 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
PDF file
MAMeredith A. Achey
Meredith A. Achey
UNUttara P. Nag
Uttara P. Nag
VRVictoria L. Robinson
Victoria L. Robinson
CRChristopher R. Reed
Christopher R. Reed
GAGowthami M. Arepally
Gowthami M. Arepally
ETElisabeth T Tracy
Elisabeth T Tracy
Bleeding and thrombosis in critically ill infants and children is a vexing clinical problem. Despite the relatively low incidence of bleeding and thrombosis in the overall pediatric population relative to adults, these critically ill children face unique challenges to hemostasis due to extreme physiologic derangements, exposure of blood to foreign surfaces and membranes, and major vascular endothelial injury or disruption. Caring for pediatric patients on extracorporeal support, recovering from solid organ transplant or invasive surgery, and after major trauma is often complicated by major bleeding or clotting events. As our ability to care for the youngest and sickest of these children increases, the gaps in our understanding of the clinical implications of developmental hemostasis have become increasingly important. We review the current understanding of the development and function of the hemostatic system, including the complex and overlapping interactions of coagulation proteins, platelets, fibrinolysis, and immune mediators from the neonatal period through early childhood and to young adulthood. We then examine scenarios in which our ability to effectively measure and treat coagulation derangements in pediatric patients is limited. In these clinical situations, adult therapies are often extrapolated for use in children without taking age-related differences in pediatric hemostasis into account, leaving clinicians confused and impacting patient outcomes. We discuss the limitations of current coagulation testing in pediatric patients before turning to emerging ideas in the measurement and management of pediatric bleeding and thrombosis. Finally, we highlight opportunities for future research which take into account this developing balance of bleeding and thrombosis in our youngest patients.

1 March 2016 in Journal of Voice
Verified
Journal Article
Closed access
MAMeredith A. Achey
Meredith A. Achey
MHMike He
Mike He
LALee M. Akst
Lee M. Akst